Actualités Invesco Global Clean Energy ETF - PBD | Actions American Stock Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Probiodrug AG Reports Third Quarter 2018 Business Update

Probiodrug / Probiodrug AG Reports Third Quarter 2018 Business Update . Processed and transmitted by West Corporation. The issuer is solely...

Probiodrug AG to Publish its Third Quarter 2018 Business Update on November 29, 2018

Probiodrug / Probiodrug AG to Publish its Third Quarter 2018 Business Update on November 29, 2018 . Processed and transmitted by West...

Probiodrug publishes SAPHIR data in peer reviewed journal

Probiodrug / Probiodrug publishes SAPHIR data in peer reviewed journal . Processed and transmitted by West Corporation. The issuer is solely...

Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act

Probiodrug / Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act . Processed and transmitted by...

Probiodrug Reports Management Changes

Probiodrug / Probiodrug Reports Management Changes . Processed and transmitted by West Corporation. The issuer is solely responsible for the...

Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy

Probiodrug / Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy . Processed and transmitted by...

Probiodrug Reports Financial Results for H1 2018 and Corporate Update

Probiodrug / Probiodrug Reports Financial Results for H1 2018 and Corporate Update . Processed and transmitted by Nasdaq Corporate Solutions. The...

Probiodrug AG to Publish First Half 2018 Results on August 30, 2018

Probiodrug / Probiodrug AG to Publish First Half 2018 Results on August 30, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The...

Ordinary General Meeting of Shareholders of Probiodrug AG

Probiodrug / Ordinary General Meeting of Shareholders of Probiodrug AG . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is...

Probiodrug AG reports First Quarter 2018 Business Update

Probiodrug / Probiodrug AG reports First Quarter 2018 Business Update . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is...

Probiodrug AG to hold its Ordinary General Meeting of Shareholders on 21 June 2018

Probiodrug / Probiodrug AG to hold its Ordinary General Meeting of Shareholders on 21 June 2018 . Processed and transmitted by Nasdaq Corporate...

Probiodrug positioning its pGlu-Abeta Antibody in the field of Abeta antibodies

Probiodrug / Probiodrug positioning its pGlu-Abeta Antibody in the field of Abeta antibodies . Processed and transmitted by Nasdaq Corporate...

Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018

Probiodrug / Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018 . Processed and transmitted by Nasdaq Corporate...

Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer

Probiodrug / Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer . Processed and transmitted by Nasdaq Corporate Solutions. The issuer...

Probiodrug reports full year 2017 financial results

Probiodrug / Probiodrug reports full year 2017 financial results . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Invesco Global Clean Energy ETF (PBD)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Invesco Global Clean Energy ETF (PBD) Actualités

Probiodrug AG Reports Third Quarter 2018 Business Update

Probiodrug AG to Publish its Third Quarter 2018 Business Update on November 29, 2018

Probiodrug publishes SAPHIR data in peer reviewed journal

Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act

Probiodrug Reports Management Changes

Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy

Probiodrug Reports Financial Results for H1 2018 and Corporate Update

Probiodrug AG to Publish First Half 2018 Results on August 30, 2018

Ordinary General Meeting of Shareholders of Probiodrug AG

Probiodrug AG reports First Quarter 2018 Business Update

Probiodrug AG to hold its Ordinary General Meeting of Shareholders on 21 June 2018

Probiodrug positioning its pGlu-Abeta Antibody in the field of Abeta antibodies

Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018

Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer

Probiodrug reports full year 2017 financial results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Invesco Global Clean Energy ETF (PBD)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Invesco Global Clean Energy ETF (PBD) Actualités

Probiodrug AG Reports Third Quarter 2018 Business Update

Probiodrug AG to Publish its Third Quarter 2018 Business Update on November 29, 2018

Probiodrug publishes SAPHIR data in peer reviewed journal

Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act

Probiodrug Reports Management Changes

Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy

Probiodrug Reports Financial Results for H1 2018 and Corporate Update

Probiodrug AG to Publish First Half 2018 Results on August 30, 2018

Ordinary General Meeting of Shareholders of Probiodrug AG

Probiodrug AG reports First Quarter 2018 Business Update

Probiodrug AG to hold its Ordinary General Meeting of Shareholders on 21 June 2018

Probiodrug positioning its pGlu-Abeta Antibody in the field of Abeta antibodies

Probiodrug AG to Publish its First Quarter 2018 Business Update on 15 May 2018

Probiodrug Appoints Dr. Ulrich Dauer as Chief Executive Officer

Probiodrug reports full year 2017 financial results

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités